This preclinical study elucidates the differential inhibitory effects of adenosine and its phosphates on platelet aggregation induced by various agonists.
Answers are grounded in this paper and cite their sources.
Does not support clinical adoption; leaves open mechanistic insights for human platelet research.
Aggregation induced by adenosine diphosphate is inhibited by adenosine as well as by adenosine mono- and triphosphate. Thrombin-induced aggregation is also inhibited by adenosine and the monophosphate, but the triphosphate at a similar concentration is not inhibitory. Aggregation induced by tri-ethyl tin is accelerated by a critical concentration of triphosphate and delayed by a higher concentration. The tri-ethyl tin effect is inhibited by 5-hydroxytryptamine and by tryptamine. Platelets from patients treated with reserpine respond normally to these last two substances. Incubated platelets lose first their ability to respond normally to tri-ethyl tin, then to thrombin, and lastly to adenosine diphosphate. These results are briefly discussed.
No takes yet. Share an insight, caveat, or question.
John O’Brien (1963) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: